Relapsing fever overview: Difference between revisions

Jump to navigation Jump to search
 
(43 intermediate revisions by the same user not shown)
Line 2: Line 2:
{{Relapsing fever}}
{{Relapsing fever}}
{{CMG}}[[Roghayeh Marandi]]<br>
{{CMG}}[[Roghayeh Marandi]]<br>
keywords:RF: Relapsing fever, TBRF: Tick-borne relapsing fever, LBRF: Louse-borne relapsing fever


==Overview==
==Overview==
[[Relapsing fever]] is a [[bacterial infection]] caused by several species of [[spirochete]] [[bacteria]] in the [[Borrelia]] family.<ref name=Schwan_1996>{{cite journal |author=Schwan T |title=Ticks and [[Borrelia]]: model systems for investigating pathogen-arthropod interactions |journal=Infect Agents Dis |volume=5 |issue=3 |pages=167-81 |year=1996 |pmid=8805079}}</ref> It is a [[vector (biology)|vector-borne disease]] that is transmitted through [[louse]] or soft-bodied [[tick bites]].<ref name=Schwan_2002>{{cite journal | author=Schwan T, Piesman J | title=Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks. | journal=Emerg Infect Dis | volume=8 | issue=2 | pages=115-21 | year=2002 | url=http://www.cdc.gov/ncidod/eid/vol8no2/01-0198.htm |id=PMID 11897061 }}</ref>
[[Relapsing fever]] is a [[bacterial infection]] caused by several species of [[spirochete]] [[bacteria]] in the [[Borrelia]] family.It is a [[vector (biology)|vector-borne disease]] that is transmitted through [[louse]] or soft-bodied [[tick bites]].


==Historical Perspective==
==Historical Perspective==
Line 11: Line 10:


==Classification==
==Classification==
There are two major forms of relapsing fever: [[Tick-borne relapsing fever|ENDEMIC TICK BORNE]] and [[Tick-borne relapsing fever|EPIDEMIC LOUSE BORNE]]. [[Tick-borne relapsing fever|TBRF]] is transmitted by the soft body [[ticks]] ([[vectors]]) from a small mammal reservoir and maybe [[endemic]] or [[sporadic]]. [[Louse-borne relapsing fever|LBRF]] is transmitted person-to-person by human body lice ([[vectors]]) from an infected human reservoir. In the early 1900s, many large [[epidemics]] were described, predominantly in Africa, the MiddleEast, India, and China. With improved hygiene, the [[incidence]] of [[epidemic]] [[relapsing fever]] has declined in the 20th century, but the disease continues to be a problem in countries of Africa and South America.
There are two major forms of relapsing fever: [[Tick-borne relapsing fever|endemic tick-borne]] and [[Tick-borne relapsing fever|epidemic louse-borne]]. [[Tick-borne relapsing fever|TBRF]] is transmitted by the soft body [[ticks]] ([[vectors]]) from a small mammal reservoir and maybe [[endemic]] or [[sporadic]]. [[Louse-borne relapsing fever|LBRF]] is transmitted person-to-person by human body lice ([[vectors]]) from an infected human reservoir.


==Pathophysiology==
==Pathophysiology==
[[Borrelia]] is usually transmitted via the [[tick bite]] or [[body louse]] to the human host. After entering the [[bloodstream]], [[spirochetes]] replicate [[Extracellular|extracellularly]] and remain predominantly in the [[plasma]] space. Patients generally remain [[asymptomatic]] until high-level [[spirochetemia]] (104-108 organisms m!) develops, at which time symptoms begin abruptly. Organisms are cleared predominantly by opsonizing [[antibodies]] with the resolution of symptoms ( [[afebrile]] period), followed several days or weeks later by the reemergence of a new [[antigenic]] strain, high-level [[spirochetemia]], and recurrence of symptoms. There are multiple [[genes]] in the [[spirochete]] encoding [[variable]] [[membrane]] [[proteins]]( [[VMPs]]). These '''VMPs''' determine the antigenic serotype of the organism. At any given time, each [[spirochete]] has VMP genes that are [[expressed]] and others that are [[silent]]. An [[Antigenic variation|antigenic switch]] occurs when a given [[VMP]] gene transposes from silent to an expressed [[locus]]. This cyclical process of initially effective [[immune response]] followed by [[antigenic variation]] and [[immunologic]] escape is responsible for the relapsing nature of this illness.
[[Borrelia]] is usually transmitted via the [[tick bite]] or [[body louse]] to the human host. After entering the [[bloodstream]], [[spirochetes]] replicate [[Extracellular|extracellularly]] and remain predominantly in the [[plasma]] space. Patients generally remain [[asymptomatic]] until high-level [[spirochetemia]] develops, at which time [[symptoms]] begin abruptly. Organisms are cleared predominantly by [[Opsonization|opsonizing]] [[antibodies]] with the resolution of [[symptoms]] ( [[afebrile]] period), followed several days or weeks later by the reemergence of a new [[antigenic]] strain, high-level [[spirochetemia]], and recurrence of symptoms. There are multiple [[genes]] in the [[spirochete]] encoding [[variable]] [[membrane]] [[proteins]]( [[VMPs]]). These '''VMPs''' determine the [[antigenic]] [[serotype]] of the [[organism]]. At any given time, each [[spirochete]] has VMP [[genes]] that are [[expressed]] and others that are [[silent]]. An [[Antigenic variation|antigenic switch]] occurs when a given [[VMP]] gene transposes from silent to an expressed [[locus]]. This cyclical process of initially effective [[immune response]] followed by [[antigenic variation]] and [[immunologic]] escape is responsible for the relapsing nature of this illness.


==Causes==
==Causes==
[[Relapsing fever]] is a [[bacterial infection]] caused by several species of [[spirochete]] [[bacteria]] in the [[Borrelia]] family. [[Tick-borne relapsing fever|TBRF]] is caused by more than 15 [[Borrelia]] species: [[Borrelia]] hermsii, [[Borrelia]] turicatae, [[Borrelia]] parkeri, [[Borrelia]] duttonii, [[Borrelia]] johnsonii, [[Borrelia]] miyamotoi. The [[bacteria]] species associated with [[Louse-borne relapsing fever|LBRF]] is [[Borrelia recurrentis]] which has a [[genome]] so similar to B. duttonii and B. crocidurae (causes of East and West African tick-borne relapsing fever).Humans are the sole reservoirs of [[Borrelia recurrentis]], while small mammals (eg, pets, ground and tree squirrels, chipmunks) and reptiles (lizards, snakes, gopher tortoises) may serve as a reservoir for [[Tick-borne relapsing fever|tick-borne]] [[Borrelia]] species.
[[Relapsing fever]] is a [[bacterial infection]] caused by several [[species]] of [[spirochete]] [[bacteria]] in the [[Borrelia]] family. [[Tick-borne relapsing fever|TBRF]] is caused by more than 15 [[Borrelia]] species: [[Borrelia]] hermsii, [[Borrelia]] turicatae, [[Borrelia]] parkeri, [[Borrelia]] duttonii, [[Borrelia]] johnsonii, [[Borrelia]] miyamotoi. The [[bacteria]] species associated with [[Louse-borne relapsing fever|LBRF]] is [[Borrelia recurrentis]] which has a [[genome]] so similar to B. duttonii and B. crocidurae (causes of East and West African tick-borne relapsing fever).Humans are the sole reservoirs of [[Borrelia recurrentis]], while small mammals (eg, pets, ground and tree squirrels, chipmunks) and reptiles (lizards, snakes, gopher tortoises) may serve as a reservoir for [[Tick-borne relapsing fever|tick-borne]] [[Borrelia]] species.


==Differentiating Relapsing fever from Other Diseases==
==Differentiating Relapsing fever from Other Diseases==
Line 24: Line 23:


==Epidemiology and Demographics==
==Epidemiology and Demographics==
[[Tick-borne relapsing fever|TBRF]] is endemic in the western US, southern British Columbia, plateau regions of Mexico, Central and South America, the Mediterranean, Central Asia, and much of Africa. In the United States. [[Louse-borne relapsing fever|LBRF]] is mainly a disease of the developing world. It is currently seen in Ethiopia and Sudan. [[Famine]], war, overcrowding, and the movement of refugee groups often result in [[Louse-borne relapsing fever|LBRF]] epidemics. With antibiotic treatment, the [[mortality]] of [[epidemic]] [[relapsing fever]] decreases from 10% to 40% to 2% to 4%.
[[Tick-borne relapsing fever|TBRF]] is [[endemic]] in the western US, southern British Columbia, plateau regions of Mexico, Central, and South America, the Mediterranean, Central Asia, and much of Africa. In the United States. [[Louse-borne relapsing fever|LBRF]] is mainly a disease of the developing world. It is currently seen in Ethiopia and Sudan. [[Famine]], war, overcrowding, and the movement of refugee groups often result in [[Louse-borne relapsing fever|LBRF]] [[epidemics]]. With antibiotic treatment, the [[mortality]] of [[epidemic]] [[relapsing fever]] decreases from 10% to 40% to 2% to 4%.


==Risk Factors==
==Risk Factors==
Line 39: Line 38:


===Diagnostic Study of Choice===
===Diagnostic Study of Choice===
The gold-standard diagnosis for relapsing fever is direct [[microscopic]] visualization of [[borreliae]] in a [[Giemsa-stained]] thick blood smears.
The gold-standard diagnosis for relapsing fever is [[Microscopic examination|direct [[microscopic<nowiki>]]</nowiki> visualization]] of [[borreliae]] in a [[Giemsa stain|Giemsa-stained]] thick [[blood smears]].


===History and Symptoms===
===History and Symptoms===
Common symptoms of relapsing fever include sudden onset of high [[fever]], [[chills]], [[headache]], [[myalgias]], and [[weakness]], occur within 3-7 days (up to 18 days)  after exposure. Less common symptoms include [[anorexia]], [[nausea]], [[vomiting]], [[abdominal pain]], [[arthralgias]], [[neck pain]] or [[back pain]], [[confusion]], [[lethargy]], [[cough]], [[rash]], sore throat, and swollen [[lymph nodes]].If left untreated, rapid defervescence usually occurs in 2-6 days (range 1-13 days), often with dramatic improvement in symptoms. Most cases eventually resolve spontaneously. Occasionally, resolution ensues by '''Crisis'''. During the crisis, patients may develop [[cerebral edema]] with [[seizures]], [[cardiac failure]], or death. This stage may result in death in up to 10% of people.Occasionally, '''crisis''' occurs after resolution,which is a classic series of stages that a person will go through and may result in death in up to 10% of patients.
The symptoms of [[relapsing fever]] present 3-7 days (up to 18 days) after exposure with sudden onset of high [[fever]], [[chills]], [[headache]], [[myalgias]], and [[weakness]]. Less common symptoms include [[anorexia]], [[nausea]], [[vomiting]], [[abdominal pain]], [[arthralgias]], [[neck pain]] or [[back pain]], [[confusion]], [[lethargy]], [[cough]], [[rash]], sore throat, and swollen [[lymph nodes]].If left untreated, rapid defervescence usually occurs in 2-6 days (range 1-13 days), often with dramatic improvement in symptoms. Most cases eventually resolve spontaneously.The clinical manifestations of [[Tick-borne relapsing fever|tick-borne]] and [[louse-borne relapsing fever]] are similar but can be quite variable, depending on the infecting strain of [[Borrelia]] and the host's [[immunity]].


===Physical Examination===
===Physical Examination===
Line 48: Line 47:


===Laboratory Findings===
===Laboratory Findings===
The presence of [[spirochetes]] in smears of peripheral [[blood]], [[bone marrow]], or [[cerebrospinal fluid]] in a [[symptomatic]] person is diagnostic of [[relapsing fever]]. Mild [[PMNs|polymorphonuclear]] [[leukocytosis]] and [[thrombocythemia]] may occur. Serologic tests for [[syphilis]] and [[Lyme disease]] may be falsely positive.
The presence of [[spirochetes]] in [[Peripheral blood smear|smears of peripheral blood]], [[bone marrow]], or [[cerebrospinal fluid]] in a [[symptomatic]] person is [[diagnostic]] of [[relapsing fever]].
 
The [[diagnosis]] of [[relapsing fever]] is confirmed by the identification of the borrelia in the patient's [[blood]] under [[microscopy]]. Laboratory tests may also reveal mild [[anemia]] with normal to increased [[leukocyte]] count. Biochemistry may reveal Mildly increased serum [[bilirubin]] and hepatic [[aminotransferase]] level, increased [[Urea|urea nitrogen]], [[creatinine]], Elevated [[ESR]].
===Electrocardiogram===
Slightly prolonged [[coagulation|coagulation tests]], [[PT]] and [[APTT]], as well as [[proteinuria]] or [[hematuria]], are also common
There are no [[ECG]] findings associated with [[relapsing fever]]. However, an ECG may be helpful in the diagnosis of complications of [[relapsing fever]]. A [[QT-interval prolongation|prolonged corrected Q-T interval]] on [[electrocardiography]] may be present in persons with RF-induced [[myocarditis]].
===Imaging Findings===
 
[[Chest radiographs]] are usually clear but may show [[pulmonary edema]] or [[Pulmonary consolidation|pneumonic consolidation]].Ultrasound may be helpful in the diagnosis of [[hepatomegaly]] or [[splenomegaly]] associated with [[relapsing fever]]. CT scan may be helpful in the diagnosis of complications of [[relapsing fever]], which include [[cerebral hemorrhage]].
===X-ray===
Chest radiographs are usually clear but may show [[pulmonary edema]] or [[Pulmonary consolidation|pneumonic consolidation]].
 
===Echocardiography and Ultrasound===
There are no echocardiography or Ultrasound findings associated with [[relapsing fever]]. However, an Ultrasound may be helpful in the diagnosis of [[hepatomegaly]] or [[splenomegaly]] associated with [[relapsing fever]].
 
===CT scan===
There are no CT scan findings associated with [[relapsing fever]]. However, a CT scan may be helpful in the diagnosis of complications of [[relapsing fever]], which include [[cerebral hemorrhage]].
 
===MRI===
There are no MRI findings associated with [[relapsing fever]]. However, an MRI may be helpful in the diagnosis of complications of [[relapsing fever]], which include [[CNS]] involvement.
 
===Other Imaging Findings===
There are no other imaging findings associated with [[relapsing fever]].


===Other Diagnostic Studies===
===Other Diagnostic Studies===
Direct and indirect [[immunofluorescence]] and experimental [[polymerase chain reaction]] testing are available in some laboratories. Analysis of [[CSF]] is indicated if signs of [[meningitis]] or [[meningoencephalitis]] are available shows [[mononuclear]] [[pleocytosis]], a mildly to the moderately elevated [[protein]] level, and normal [[glucose]] levels in the [[CSF]] support the diagnosis of CNS [[borrelia]] infection.
Analysis of [[CSF]] is indicated if signs of [[meningitis]] or [[meningoencephalitis]] are available shows [[mononuclear]] [[pleocytosis]], a mildly to the moderately elevated [[protein]] level, and normal [[glucose]] levels in the [[CSF]] support the diagnosis of CNS [[borrelia]] infection. ECG may be helpful in the diagnosis of complications of [[relapsing fever]]. A [[QT-interval prolongation|prolonged corrected Q-T interval]] on [[electrocardiography]] may be present in persons with RF-induced [[myocarditis]].


==Treatment==
==Treatment==
Line 76: Line 61:
[[Antimicrobial agent|Antimicrobial therapy]] for [[relapsing fever]] in adults depends on the [[vector]] ([[Tick-born disease|Tick-borne]] vs. [[Louse-borne relapsing fever|Louse-borne]]) and includes either [[doxycycline]], [[erythromycin]], or [[tetracyclines]]. [[intravenous]] [[ceftriaxone]] is added if either [[meningitis]] or [[encephalitis]] is present.
[[Antimicrobial agent|Antimicrobial therapy]] for [[relapsing fever]] in adults depends on the [[vector]] ([[Tick-born disease|Tick-borne]] vs. [[Louse-borne relapsing fever|Louse-borne]]) and includes either [[doxycycline]], [[erythromycin]], or [[tetracyclines]]. [[intravenous]] [[ceftriaxone]] is added if either [[meningitis]] or [[encephalitis]] is present.


===Interventions===
=== Primary Prevention===
The mainstay treatment of relapsing fever is [[antibiotic]] therapy.
 
===Surgery===
Surgical intervention is not recommended for the management of [[relapsing fever]].
 
===Primary Prevention===
Wearing clothing that fully covers the arms and legs outdoors, Insect repellents such as [[DEET]] on the skin and clothing also work. Rodent( reservoir)  control. [[Tick]] and [[lice]] control in high-risk areas is another important public health measure. [[Epidemics]] are controlled by sterilizing clothing to eliminate lice, using [[pediculicide|pediculicides]], and by improving [[personal hygiene]].
Wearing clothing that fully covers the arms and legs outdoors, Insect repellents such as [[DEET]] on the skin and clothing also work. Rodent( reservoir)  control. [[Tick]] and [[lice]] control in high-risk areas is another important public health measure. [[Epidemics]] are controlled by sterilizing clothing to eliminate lice, using [[pediculicide|pediculicides]], and by improving [[personal hygiene]].


===Secondary Prevention===
===Secondary Prevention===
Although there is no commercially available [[vaccine]] for Relapsing fever, it is notable that infection Infection with a given strain of [[borrelia]] may cause partial protection against subsequent infection by the same strain. In some highly [[endemic]] areas, relapsing fever is more severe in newcomers than natives.
There is no commercially available [[vaccine]] for Relapsing fever, it is notable that infection with a given strain of [[borrelia]] may cause partial protection against subsequent infection by the same strain. In some highly [[endemic]] areas, [[relapsing fever]] is more severe in newcomers than natives.
 
===Cost-effective of therapy===


==References==
===Future or Investigational Therapies===
Research continues to find a [[vaccine]] against [[relapsing fever]].


==References==
==References==

Latest revision as of 19:28, 28 September 2020

Relapsing fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Relapsing fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Relapsing fever overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Relapsing fever overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Relapsing fever overview

CDC on Relapsing fever overview

Relapsing fever overview in the news

Blogs on Relapsing fever overview

Directions to Hospitals Treating Relapsing fever

Risk calculators and risk factors for Relapsing fever overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Roghayeh Marandi

Overview

Relapsing fever is a bacterial infection caused by several species of spirochete bacteria in the Borrelia family.It is a vector-borne disease that is transmitted through louse or soft-bodied tick bites.

Historical Perspective

Relapsing fever has been described since the days of Hippocrates in ancient Greeks. however, the term relapsing fever was first used by David Craigie to describe an outbreak of the disease in Edinburgh in 1843. Livingston first described tick-borne relapsing fever in 1857. The association between spirochetes and the development of louse-born relapsing fever first described by Otto Obermeier in 1873 after an outbreak in Berlin (1867–1868). Cook, Ross, Milne, Dutton, Todd, Koch, and others studied TBRF extensively throughout southern and eastern Africa in the early 1900s.In 1904, Ross and Milne, while working in Uganda, showed that TBRF was caused by a spirochete in the bloodstream. The role of the human body louse in the transmission of relapsing fever was reported by MacKie in 1907.

Classification

There are two major forms of relapsing fever: endemic tick-borne and epidemic louse-borne. TBRF is transmitted by the soft body ticks (vectors) from a small mammal reservoir and maybe endemic or sporadic. LBRF is transmitted person-to-person by human body lice (vectors) from an infected human reservoir.

Pathophysiology

Borrelia is usually transmitted via the tick bite or body louse to the human host. After entering the bloodstream, spirochetes replicate extracellularly and remain predominantly in the plasma space. Patients generally remain asymptomatic until high-level spirochetemia develops, at which time symptoms begin abruptly. Organisms are cleared predominantly by opsonizing antibodies with the resolution of symptoms ( afebrile period), followed several days or weeks later by the reemergence of a new antigenic strain, high-level spirochetemia, and recurrence of symptoms. There are multiple genes in the spirochete encoding variable membrane proteins( VMPs). These VMPs determine the antigenic serotype of the organism. At any given time, each spirochete has VMP genes that are expressed and others that are silent. An antigenic switch occurs when a given VMP gene transposes from silent to an expressed locus. This cyclical process of initially effective immune response followed by antigenic variation and immunologic escape is responsible for the relapsing nature of this illness.

Causes

Relapsing fever is a bacterial infection caused by several species of spirochete bacteria in the Borrelia family. TBRF is caused by more than 15 Borrelia species: Borrelia hermsii, Borrelia turicatae, Borrelia parkeri, Borrelia duttonii, Borrelia johnsonii, Borrelia miyamotoi. The bacteria species associated with LBRF is Borrelia recurrentis which has a genome so similar to B. duttonii and B. crocidurae (causes of East and West African tick-borne relapsing fever).Humans are the sole reservoirs of Borrelia recurrentis, while small mammals (eg, pets, ground and tree squirrels, chipmunks) and reptiles (lizards, snakes, gopher tortoises) may serve as a reservoir for tick-borne Borrelia species.

Differentiating Relapsing fever from Other Diseases

The following infectious diseases should be considered in someone with recurrent episodes of a febrile illness: Colorado tick fever,Infectious mononucleosis, Ascending cholangitis , Yellow fever, African hemorrhagic fevers, Lymphocytic choriomeningitis, Dengue fever, Leptospirosis, Infections with echovirus 9, Malaria, Chronic meningococcemia, Infections with Bartonella species, Brucellosis, Rat bite fever.

Epidemiology and Demographics

TBRF is endemic in the western US, southern British Columbia, plateau regions of Mexico, Central, and South America, the Mediterranean, Central Asia, and much of Africa. In the United States. LBRF is mainly a disease of the developing world. It is currently seen in Ethiopia and Sudan. Famine, war, overcrowding, and the movement of refugee groups often result in LBRF epidemics. With antibiotic treatment, the mortality of epidemic relapsing fever decreases from 10% to 40% to 2% to 4%.

Risk Factors

Risk factors of TBRF: Sleeping in caves, wood cabins, or earthen floored huts in areas, Risk factors of LBRF: Poor personal hygiene, overcrowding like in military camps, prisons, street children sleeping areas, civilian population disrupted by war and other disasters.

Screening

Not applicable

Natural History, Complications, and Prognosis

Most cases eventually resolve spontaneously. If left untreated, during the crisis up to 10% of patients with relapsing fever may progress to develop cerebral edema with seizures, cardiac failure, or death. Common complications of relapsing fever are iridocyclitis, meningitis, encephalitis, myocarditis, endocarditis, pneumonia, abnormal coagulation with hemorrhage, and spontaneous abortion or transplacental transmission. With early treatment, the death rate is reduced. Those who have developed coma, myocarditis, liver problems, or pneumonia are more likely to die.

Diagnosis

Diagnosis can be made by Microscopy, PCR, or serology.

Diagnostic Study of Choice

The gold-standard diagnosis for relapsing fever is [[Microscopic examination|direct [[microscopic]] visualization]] of borreliae in a Giemsa-stained thick blood smears.

History and Symptoms

The symptoms of relapsing fever present 3-7 days (up to 18 days) after exposure with sudden onset of high fever, chills, headache, myalgias, and weakness. Less common symptoms include anorexia, nausea, vomiting, abdominal pain, arthralgias, neck pain or back pain, confusion, lethargy, cough, rash, sore throat, and swollen lymph nodes.If left untreated, rapid defervescence usually occurs in 2-6 days (range 1-13 days), often with dramatic improvement in symptoms. Most cases eventually resolve spontaneously.The clinical manifestations of tick-borne and louse-borne relapsing fever are similar but can be quite variable, depending on the infecting strain of Borrelia and the host's immunity.

Physical Examination

Physical examination of patients with relapsing fever is usually remarkable for the moderately ill-appearing appearance, mild to moderately dehydration, fever, tachycardia, and hepatosplenomegaly. Less frequently lymphadenopathy, jaundice, abdominal tenderness, pulmonary rales, skin rash, meningismus, delirium, aphasia, hemiplegia, facial paralysis, or other neurologic findings may be present.

Laboratory Findings

The presence of spirochetes in smears of peripheral blood, bone marrow, or cerebrospinal fluid in a symptomatic person is diagnostic of relapsing fever. The diagnosis of relapsing fever is confirmed by the identification of the borrelia in the patient's blood under microscopy. Laboratory tests may also reveal mild anemia with normal to increased leukocyte count. Biochemistry may reveal Mildly increased serum bilirubin and hepatic aminotransferase level, increased urea nitrogen, creatinine, Elevated ESR. Slightly prolonged coagulation tests, PT and APTT, as well as proteinuria or hematuria, are also common

Imaging Findings

Chest radiographs are usually clear but may show pulmonary edema or pneumonic consolidation.Ultrasound may be helpful in the diagnosis of hepatomegaly or splenomegaly associated with relapsing fever. CT scan may be helpful in the diagnosis of complications of relapsing fever, which include cerebral hemorrhage.

Other Diagnostic Studies

Analysis of CSF is indicated if signs of meningitis or meningoencephalitis are available shows mononuclear pleocytosis, a mildly to the moderately elevated protein level, and normal glucose levels in the CSF support the diagnosis of CNS borrelia infection. ECG may be helpful in the diagnosis of complications of relapsing fever. A prolonged corrected Q-T interval on electrocardiography may be present in persons with RF-induced myocarditis.

Treatment

Medical Therapy

Antimicrobial therapy for relapsing fever in adults depends on the vector (Tick-borne vs. Louse-borne) and includes either doxycycline, erythromycin, or tetracyclines. intravenous ceftriaxone is added if either meningitis or encephalitis is present.

Primary Prevention

Wearing clothing that fully covers the arms and legs outdoors, Insect repellents such as DEET on the skin and clothing also work. Rodent( reservoir) control. Tick and lice control in high-risk areas is another important public health measure. Epidemics are controlled by sterilizing clothing to eliminate lice, using pediculicides, and by improving personal hygiene.

Secondary Prevention

There is no commercially available vaccine for Relapsing fever, it is notable that infection with a given strain of borrelia may cause partial protection against subsequent infection by the same strain. In some highly endemic areas, relapsing fever is more severe in newcomers than natives.

Cost-effective of therapy

Future or Investigational Therapies

Research continues to find a vaccine against relapsing fever.

References